|
gptkbp:instanceOf
|
gptkb:drug
gptkb:chelating_agent
gptkb:antidote
|
|
gptkbp:administeredBy
|
intramuscular injection
|
|
gptkbp:ATCCode
|
V03AB03
|
|
gptkbp:CASNumber
|
59-52-9
|
|
gptkbp:chemicalFormula
|
C3H8O2S2
|
|
gptkbp:developedBy
|
gptkb:United_Kingdom
gptkb:World_War_II
|
|
gptkbp:discoveredBy
|
1940
|
|
gptkbp:firstUsedAs
|
antidote to chemical warfare agents
|
|
gptkbp:includedIn
|
gptkb:World_Health_Organization's_List_of_Essential_Medicines
|
|
gptkbp:meltingPoint
|
62 °C
|
|
gptkbp:molecularWeight
|
124.23 g/mol
|
|
gptkbp:nameOrigin
|
antidote to lewisite
|
|
gptkbp:otherName
|
gptkb:dimercaprol
|
|
gptkbp:sideEffect
|
nausea
vomiting
hypertension
tachycardia
pain at injection site
|
|
gptkbp:solubility
|
insoluble in water
soluble in alcohol
|
|
gptkbp:usedFor
|
treatment of antimony poisoning
treatment of arsenic poisoning
treatment of gold poisoning
treatment of lead poisoning
treatment of lewisite poisoning
treatment of mercury poisoning
|
|
gptkbp:bfsParent
|
gptkb:BAL
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
British Anti-Lewisite
|